Charles Schwab’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$82M Sell
4,447,367
-263,913
-6% -$4.87M 0.01% 773
2025
Q1
$82.3M Buy
4,711,280
+6,317
+0.1% +$110K 0.02% 754
2024
Q4
$81.5M Buy
4,704,963
+3,082
+0.1% +$53.4K 0.02% 782
2024
Q3
$87.5M Buy
4,701,881
+365,855
+8% +$6.81M 0.02% 745
2024
Q2
$66.8M Buy
4,336,026
+87,514
+2% +$1.35M 0.01% 853
2024
Q1
$62.8M Buy
4,248,512
+57,925
+1% +$856K 0.01% 860
2023
Q4
$59.8M Buy
4,190,587
+94,304
+2% +$1.35M 0.02% 852
2023
Q3
$57.1M Buy
4,096,283
+116,444
+3% +$1.62M 0.02% 795
2023
Q2
$46.8M Buy
3,979,839
+18,926
+0.5% +$223K 0.01% 892
2023
Q1
$45.6M Buy
3,960,913
+56,583
+1% +$651K 0.01% 907
2022
Q4
$48.5M Buy
3,904,330
+89,808
+2% +$1.12M 0.02% 837
2022
Q3
$50M Buy
3,814,522
+29,954
+0.8% +$393K 0.02% 755
2022
Q2
$52.9M Buy
3,784,568
+163,373
+5% +$2.28M 0.02% 717
2022
Q1
$53.9M Buy
3,621,195
+193,550
+6% +$2.88M 0.02% 825
2021
Q4
$46.4M Buy
3,427,645
+285,064
+9% +$3.86M 0.01% 948
2021
Q3
$46.3M Buy
3,142,581
+205,496
+7% +$3.02M 0.02% 931
2021
Q2
$53.5M Buy
2,937,085
+63,741
+2% +$1.16M 0.02% 814
2021
Q1
$49.9M Buy
2,873,344
+8,895
+0.3% +$154K 0.02% 829
2020
Q4
$49.8M Buy
2,864,449
+46,470
+2% +$807K 0.02% 769
2020
Q3
$38.8M Sell
2,817,979
-24,002
-0.8% -$331K 0.02% 793
2020
Q2
$41M Buy
2,841,981
+527,377
+23% +$7.61M 0.02% 706
2020
Q1
$25.3M Buy
2,314,604
+428,199
+23% +$4.68M 0.01% 851
2019
Q4
$40.3M Buy
1,886,405
+478,800
+34% +$10.2M 0.02% 751
2019
Q3
$32.3M Buy
1,407,605
+112,387
+9% +$2.58M 0.02% 854
2019
Q2
$25.5M Buy
1,295,218
+15,022
+1% +$296K 0.02% 977
2019
Q1
$24.9M Buy
1,280,196
+19,809
+2% +$386K 0.02% 969
2018
Q4
$20.8M Buy
1,260,387
+24,308
+2% +$401K 0.02% 976
2018
Q3
$28.6M Buy
1,236,079
+21,567
+2% +$499K 0.02% 899
2018
Q2
$26.4M Buy
1,214,512
+64,647
+6% +$1.4M 0.02% 886
2018
Q1
$20.3M Buy
1,149,865
+72,029
+7% +$1.27M 0.02% 992
2017
Q4
$20.2M Sell
1,077,836
-62,298
-5% -$1.17M 0.02% 969
2017
Q3
$25M Buy
1,140,134
+580,906
+104% +$12.7M 0.02% 757
2017
Q2
$13.5M Buy
559,228
+57,014
+11% +$1.37M 0.01% 1126
2017
Q1
$14M Sell
502,214
-57,813
-10% -$1.61M 0.01% 1068
2016
Q4
$13.7M Buy
560,027
+25,343
+5% +$619K 0.02% 1026
2016
Q3
$13.5M Buy
534,684
+199,870
+60% +$5.03M 0.02% 947
2016
Q2
$6.91M Buy
334,814
+26,038
+8% +$537K 0.01% 1329
2016
Q1
$6.2M Buy
308,776
+10,886
+4% +$219K 0.01% 1376
2015
Q4
$6.03M Buy
297,890
+31,004
+12% +$627K 0.01% 1385
2015
Q3
$6.19M Buy
266,886
+23,024
+9% +$534K 0.01% 1331
2015
Q2
$6.28M Buy
243,862
+16,100
+7% +$414K 0.01% 1399
2015
Q1
$7.55M Sell
227,762
-4,324
-2% -$143K 0.01% 1204
2014
Q4
$7.05M Buy
232,086
+61,803
+36% +$1.88M 0.01% 1164
2014
Q3
$4.14M Buy
170,283
+12,582
+8% +$306K 0.01% 1531
2014
Q2
$4.53M Buy
157,701
+21,921
+16% +$629K 0.01% 1483
2014
Q1
$3.79M Buy
135,780
+16,200
+14% +$452K 0.01% 1549
2013
Q4
$3.13M Buy
119,580
+15,887
+15% +$415K 0.01% 1624
2013
Q3
$2.46M Buy
103,693
+10,071
+11% +$239K 0.01% 1721
2013
Q2
$2.47M Buy
+93,622
New +$2.47M 0.01% 1624